Unibest
← Back to patent-cliff list

CAS 873-74-5

4-aminobenzonitrile

Codes: RILP-028, DABI-014, ETRA-002

Application context (from source-drug indications)

HIV infectionRilpivirine HydrochlorideHepatic function declineRilpivirine HydrochlorideAcquired immunodeficiency syndromeRilpivirine HydrochlorideContraceptive useRilpivirine HydrochlorideVenous thromboembolismDabigatran Etexilate MesylateEmbolismDabigatran Etexilate MesylateStrokeDabigatran Etexilate MesylateIschaemic strokeDabigatran Etexilate MesylatePulmonary embolismDabigatran Etexilate MesylateVenous thrombosisDabigatran Etexilate MesylateHIV infectionEtravirineFriedreich's ataxiaEtravirineInflammatory diseaseEtravirineInsulin resistanceEtravirine

Source drugs (routes using this intermediate)

DrugTierExpiry
Rilpivirine HydrochlorideTier B — Position early-
Dabigatran Etexilate MesylateTier B — Position early-
EtravirineTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API WorksDabigatran etexilate mesylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Siteethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like SiteN-(4-cyanophenyl)-Glycine
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.